Humanigen Inc (HGENQ)

[LongTkt]

Previous Look at the Global COVID Market

The COVID vaccine won't be ready for mass distribution until June 2021. It will be similar to the flu vaccine so 50% of the population choose to get the vaccine and the vaccine is 50% effective for those that receive it. That means only 25% of the world will be successfully vaccinated from COVID by October 2021.

There is also growing evidence that the general population can be re-infected by COVID only a few months after recovering from a first infection; but this analysis doesn't take that into account. Research also suggests that people with COVID who are asymptomatic will likely be re-infected with a more severe immune response. Yes, currently 20% of COVID infections result in a hospital stay but I'm ignoring who is hospitalized vs. outpatient.

Someone on the CYDY forum mentioned that the company should offer a dividend. If HGEN is NOT bought out, then I think there is potential for HGEN to do so as well.

CYDY Global COVID Market iHub post

Here's a version for HGEN:





I'm pretty comfortable with $1.3 trillion dollar global market prediction for COVID-19 treatment. Here are my reasons why.

I think HGEN has nearly limitless COVID revenue potential; even if they only capture 10% of the global market.